BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 220 found
  Current Search:  fda: 17515, emea: 434, cder: 109, regulatori: 7110     

HTML
61%
Catalent to Present Webinar on Regulatory Documents Surrounding Extractables and Leachables Testing Requiremen
Author: Jennings and Co.

Industry: Pharmaceuticals Research Triangle Park, NC, March 12, 2010 Catalent Pharma Solutions will host a free webinar featuring Principal Scientist, Alan D.

Hendricker, Ph.

The one-hour webinar provides an introduction to the ...

Express Press Release:  Mar 12 2010 9:19AM
Matching: fda emea regulatori
Find similar documents
HTML
100%
From Harmonization to Inspections: An FDA Update
A talk with FDAs CDER Office of Compliance's Division of Manufacturing and Product Quality about the state of regulatory harmonization, enforcement, and priorities for the future.

To cast your vote, log in or become a member.

This quick,...

Pharmaceutical Manufacturing Magazine:  Mar 11 2010 4:41PM
Matching: fda emea cder regulatori
Find similar documents
HTML
61%
AutekBio, Suma Ventures & Beijing E-Town to Invest in the Largest CMO Project in Asia
BEIJING(BUSINESS WIRE) AutekBio, Inc., SUMA Ventures and Beijing E-Town Harvest International Capital Management Corporation, a venture capital group from Beijing Municipal Government announced a joint investment of more than US$100m to develop a new contract...
Pharmacy Choice:  Mar 11 2010 5:27PM
Matching: fda emea regulatori
Find similar documents
HTML
61%
AutekBio, Suma Ventures And Beijing E-Town To Invest In The Largest CMO Project In Asia
AutekBio, Inc., SUMA Ventures and Beijing E-Town Harvest International Capital Management Corporation, a venture capital group from Beijing Municipal Government announced a joint investment of more than US$100m to develop a new contract manufacturing...
Pharmaceutical Online:  Mar 11 2010 6:52AM
Matching: fda emea regulatori
Find similar documents
HTML
61%
AutekBio, Suma Ventures & Beijing E-Town to Invest in the Largest CMO Project in Asia
- AutekBio, Inc., SUMA Ventures and Beijing E-Town Harvest International Capital Management Corporation, a venture capital group from Beijing Municipal Government announced a joint investment of more than US$100m to develop a new contract manufacturing...
Pharma Live:  Mar 11 2010 12:06AM
Matching: fda emea regulatori
Find similar documents
HTML
61%
Jyske Bank, Danske Equities upgrade Danish Bavarian Nordic after Prostvac news
- Jyske Bank and Danske Equities have upgraded their ratings on Bavarian Nordic A/S (CPH: BAVA) to 'buy' and 'accumulate', respectively, after the Danish biotech company yesterday said its Phase III plans for prostate cancer vaccine candidate Prostvac were...
Pharmacy Choice:  Mar 10 2010 9:09PM
Matching: fda emea regulatori
Find similar documents
HTML
61%
AutekBio, Suma Ventures & Beijing E-Town to Invest in the Largest CMO Project in Asia
BEIJING--(BUSINESS WIRE)--AutekBio, Inc., SUMA Ventures and Beijing E-Town Harvest International Capital Management Corporation, a venture capital group from Beijing Municipal Government announced a joint investment of more than US$100m to develop a new...
Yahoo! Canada:  Mar 10 2010 2:56PM
Matching: fda emea regulatori
Find similar documents
HTML
68%
Orexigen(R) Therapeutics Appoints Peter Honig, M.D. to Board of Directors
SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- Orexigen Therapeutics, Inc.

(Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced the appointment of Peter K.

Honig, MD, MPH to its board of directors.

long_spaceDr.

KOTA Territory News:  Mar 4 2010 6:47PM
Matching: fda cder regulatori
Find similar documents
HTML
61%
NicOx 2009 Financial Results
NicOx S.A.

(NYSE Euronext Paris: COX) today announced its financial results for full year 2009 and provided an overview of its activities, in particular those related to its lead compound naproxcinod, which is currently under review by the US Food and Drug...

Street Insider:  Mar 4 2010 6:39PM
Matching: fda emea regulatori
Find similar documents
HTML
61%
NicOx 2009 Financial Results
NicOx S.A.

(NYSE Euronext Paris: COX) today announced its financial results for full year 2009 and provided an overview of its activities, in particular those related to its lead compound naproxcinod, which is currently under review by the US Food and Drug...

Street Insider:  Mar 4 2010 6:37PM
Matching: fda emea regulatori
Find similar documents
HTML
68%
Orexigen Therapeutics Appoints Peter Honig, M.D. to Board of Directors
SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- Orexigen Therapeutics, Inc.

( NASDAQ:OREX) , a biopharmaceutical company focused on the treatment of obesity, today announced the appointment of Peter K.

Honig, MD, MPH to its board of directors.

Honig brings...

Pharma Live:  Mar 3 2010 8:09AM
Matching: fda cder regulatori
Find similar documents
HTML
68%
Orexigen(R) Therapeutics Appoints Peter Honig, M.D. to Board of Directors
Category: General News Font Size SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- Orexigen Therapeutics, Inc.

(Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced the appointment of Peter K.

Honig, MD, MPH to its...

MedIndia:  Mar 3 2010 2:36AM
Matching: fda cder regulatori
Find similar documents
HTML
68%
Honig Named To Orexigen Therapeutics Board
(Comment on this article at http://www.financialwire.net/2010/03/03/honig-named-to-orexigen-therapeutics-board/) Honig most recently served as senior vice president of Worldwide Regulatory Affairs and Product Safety at Merck and co-chair of Merck's Late...
TradingMarkets:  Mar 3 2010 5:23PM
Matching: fda cder regulatori
Find similar documents
HTML
68%
Honig Named To Orexigen Therapeutics Board - Zibb.com
Companies: Isolyser Company, Inc.

(OREX), Merck & Co., Inc.

(MRK) (Comment on this article at http://www.financialwire.net/2010/03/03/honig-named-to-orexigen-therapeutics-board/) Honig most recently served as senior vice president of Worldwide ...

Zibb:  Mar 3 2010 5:01PM
Matching: fda cder regulatori
Find similar documents
HTML
61%
Nycomed on track in 2009 with strong growth in Key Products
Nycomed was on track in 2009, with strong growth in Key Products and most emerging markets.

Pantoprazole sales were resilient after the loss of exclusivity in May in 12 European countries, as a result of a tailored approach to each region.

The pipeline...

World Pharma News:  Mar 3 2010 9:23AM
Matching: fda emea regulatori
Find similar documents
HTML
68%
Orexigen(R) Therapeutics Appoints Peter Honig, M.D. to Board of Directors
SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- Orexigen Therapeutics, Inc.

(Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced the appointment of Peter K.

Honig, MD, MPH to its board of directors.

Honig brings...

SmartBrief:  Mar 2 2010 7:58PM
Matching: fda cder regulatori
Find similar documents
HTML
68%
Orexigen(R) Therapeutics Appoints Peter Honig, M.D. to Board of Directors
Orexigen Therapeutics, Inc.

(Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced the appointment of Peter K.

Honig, MD, MPH to its board of directors.

Honig brings over 20 years of clinical and regulatory...

San Jose Business Journal:  Mar 2 2010 3:33PM
Matching: fda cder regulatori
Find similar documents
HTML
68%
Orexigen(R) Therapeutics Appoints Peter Honig, M.D. to Board of Directors
Orexigen Therapeutics, Inc.

(Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced the appointment of Peter K.

Honig, MD, MPH to its board of directors.

Honig brings over 20 years of clinical and regulatory...

Austin Business Journal:  Mar 2 2010 1:40PM
Matching: fda cder regulatori
Find similar documents
HTML
68%
Orexigen(R) Therapeutics Appoints Peter Honig, M.D. to Board of Directors
SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- Orexigen Therapeutics, Inc.

(Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced the appointment of Peter K.

Honig, MD, MPH to its board of directors.

Honig brings...

PR Newswire:  Mar 2 2010 1:38PM
Matching: fda cder regulatori
Find similar documents
HTML
68%
Orexigen(R) Therapeutics Appoints Peter Honig, M.D. to Board of Directors
SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- Orexigen Therapeutics, Inc.

(Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced the appointment of Peter K.

Honig, MD, MPH to its board of directors.

Honig brings...

Yahoo! Canada:  Mar 2 2010 5:22PM
Matching: fda cder regulatori
Find similar documents
HTML
68%
Orexigen(R) Therapeutics Appoints Peter Honig, M.D. to Board of Directors
SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- Orexigen Therapeutics, Inc.

(Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced the appointment of Peter K.

Honig, MD, MPH to its board of directors.

long_spaceDr.

KSLA:  Mar 2 2010 7:55PM
Matching: fda cder regulatori
Find similar documents
HTML
61%
Another Strong Alert!! Sign Up Today For Our Free Newsletter!! GHLV,IKTO,HSCO,VSTNQ,NUBL,IWEB
STOCK MARKETING INC PRESENTS : (OTCBB: GHLV) Global Health Ventures, Inc., (OTCBB: IKTO) iTokk, Inc., (PINKSHEETS: HSCO) Hi Score Corp., (PINKSHEETS: VSTNQ) Visteon Corp., (OTCBC: NUBL) Numobile, Inc., (OTCBB: IWEB) IceWEB, Inc.

StockMarketingInc.com To sign...

Pharmacy Choice:  Mar 2 2010 2:56AM
Matching: fda emea regulatori
Find similar documents
HTML
61%
FDA, EMEA adopt orphan drug report system
ROCKVILLE,Md.

(Mar.

1) Companies developing drugs to treat especially rare conditions may find winning regulatory approval in the United States and European Union a bit easier under a plan adopted by regulators on both sides of the Atlantic.

The...

Drug Store News:  Mar 1 2010 4:41PM
Matching: fda emea regulatori
Find similar documents
HTML
61%
Asterand Announces the Launch of Good Laboratory Practice (GLP) Molecular Pathology Services
Initial Offering will be Tissue Cross Reactivity Testing to meet FDA and EMEA Requirements DETROIT--(BUSINESS WIRE)--Mar 1, 2010 - Asterand plc (LSE: ATD), a leading provider of human tissue and human tissue-based services to pharmaceutical and...
Pharma Live:  Mar 1 2010 9:58PM
Matching: fda emea regulatori
Find similar documents
HTML
61%
Asterand Announces the Launch of Good Laboratory Practice (GLP) Molecular Pathology Services
Initial Offering will be Tissue Cross Reactivity Testing to meet FDA and EMEA Requirements DETROIT(BUSINESS WIRE) Asterand plc (LSE: ATD), a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology...
Pharmacy Choice:  Mar 1 2010 4:18PM
Matching: fda emea regulatori
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.